Clarus Lifesciences III, L.P. — Form D/A
Clarus Lifesciences III, L.P. of CAMBRIDGE, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2014-06-19. The offering totals $375.0M, of which $234.2M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2014-06-19
- Form: D/A
- Accession: 0001597143-14-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $375.0M
- Amount sold: $234.2M
- Remaining: $140.8M
- Investors: 16
- Date of first sale: 2014-02-07
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-211426
Issuer
- Name: Clarus Lifesciences III, L.P.
- CIK: 0001597143
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 101 MAIN STREET, CAMBRIDGE, MA, 02142
- Phone: 617-949-2200
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| N/A Clarus Ventures III GP, L.P. | Director | Cambridge, MA |
| N/A Clarus Ventures III, LLC | Director | Cambridge, MA |
| Nicholas Galakatos | Executive Officer | New York, NY |
| Dennis Henner | Executive Officer | Burlingame, CA |
| Robert W Liptak | Executive Officer | Cambridge, MA |
| Nicholas J Simon | Executive Officer | Cambridge, MA |
| Kurt C Wheeler | Executive Officer | Mt. Olive, NJ |
Other filings by this issuer (1)
More